[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2002232788A1 - Self forming, thermodynamically stable liposomes and their applications - Google Patents

Self forming, thermodynamically stable liposomes and their applications

Info

Publication number
AU2002232788A1
AU2002232788A1 AU2002232788A AU3278802A AU2002232788A1 AU 2002232788 A1 AU2002232788 A1 AU 2002232788A1 AU 2002232788 A AU2002232788 A AU 2002232788A AU 3278802 A AU3278802 A AU 3278802A AU 2002232788 A1 AU2002232788 A1 AU 2002232788A1
Authority
AU
Australia
Prior art keywords
thermodynamically stable
applications
stable liposomes
self forming
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232788A
Inventor
Brian Keller Keller
Dan D. Lasic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biozone Laboratories Inc
Original Assignee
Biozone Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24996074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002232788(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biozone Laboratories Inc filed Critical Biozone Laboratories Inc
Publication of AU2002232788A1 publication Critical patent/AU2002232788A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Certain diacylglycerol-polyethyleneglycol (DAG-PEG) lipids are especially useful for forming thermodynamically stable liposomes. Such liposomes are useful for a variety of purposes, including the delivery of therapeutic agents.
AU2002232788A 2000-12-20 2001-12-19 Self forming, thermodynamically stable liposomes and their applications Abandoned AU2002232788A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/745,292 2000-12-20
US09/745,292 US6610322B1 (en) 2000-12-20 2000-12-20 Self forming, thermodynamically stable liposomes and their applications
PCT/US2001/050118 WO2002049617A2 (en) 2000-12-20 2001-12-19 Self forming, thermodynamically stable liposomes and their applications

Publications (1)

Publication Number Publication Date
AU2002232788A1 true AU2002232788A1 (en) 2002-07-01

Family

ID=24996074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232788A Abandoned AU2002232788A1 (en) 2000-12-20 2001-12-19 Self forming, thermodynamically stable liposomes and their applications

Country Status (7)

Country Link
US (5) US6610322B1 (en)
EP (1) EP1343475B1 (en)
JP (2) JP4497765B2 (en)
AT (1) ATE429901T1 (en)
AU (1) AU2002232788A1 (en)
DE (1) DE60138566D1 (en)
WO (1) WO2002049617A2 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230088B2 (en) 2001-07-03 2007-06-12 Mallinckrodt, Inc. Compounds for dual photodiagnosis and therapy
US6673334B1 (en) * 2000-10-16 2004-01-06 Mallinkcrodt, Inc. Light sensitive compounds for instant determination of organ function
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
US6669926B1 (en) 2000-10-16 2003-12-30 Mallinckrodt, Inc. Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
WO2002087541A1 (en) * 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
US20030003144A1 (en) * 2001-05-01 2003-01-02 Keller Brian C. Sustained release formulations for nifedipine, dextromethorphan, and danazol
CN1245153C (en) * 2002-06-06 2006-03-15 上海家化联合股份有限公司 A kind of vitamin A liposome and preparation method thereof
US7785623B2 (en) * 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp Stabilized topotecan liposomal composition and methods
EP1559790A1 (en) * 2004-02-02 2005-08-03 International University Bremen Gmbh Vesicles for the removal of substances from liquids
US8664392B2 (en) 2004-12-23 2014-03-04 Medibeacon, LLC Pyrazine derivatives for bioconjugation
JP5303269B2 (en) * 2005-06-06 2013-10-02 学校法人早稲田大学 Bone marrow-directed drug delivery materials and uses thereof
US20070009467A1 (en) * 2005-07-05 2007-01-11 Biozone Laboratories, Inc. Spray-on makeup to simulate the appearance of wearing hosiery
WO2007103250A2 (en) * 2006-03-02 2007-09-13 Mallinckrodt Inc. Thiadiazole compounds and their use in phototherapy
CN101400658A (en) * 2006-03-10 2009-04-01 马林克罗特公司 Photoactive compounds and compositions and uses thereof
WO2007115132A2 (en) * 2006-03-29 2007-10-11 Guilford F Timothy Radiopharmaceutical in self-forming liposomal formulation capable of multipath administration including other ingredients
ES2456042T3 (en) 2006-06-22 2014-04-21 Medibeacon, LLC Pyrazine derivatives and their uses in renal monitoring
US7794595B2 (en) * 2006-08-28 2010-09-14 Brian Charles Keller Method for encapsulation, remediation and recovery of spilled oil
CA2600220C (en) * 2006-09-07 2014-12-09 Canadian Blood Services Surface cross-linked lipidic particles, methods of production and uses therefor
CN103480026A (en) * 2007-03-08 2014-01-01 莫科治疗有限公司 Scar dressing formulation
WO2008121721A2 (en) * 2007-03-28 2008-10-09 Portola Pharmaceuticals, Inc. Targeted delivery and expression of procoagulant hemostatic activity
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US20090035236A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
JP5281645B2 (en) * 2007-09-08 2013-09-04 イーエルシー マネージメント エルエルシー Ferulic acid resveratrol compounds, compositions containing these compounds and methods for their use.
US20090176795A1 (en) * 2008-01-04 2009-07-09 Brian Charles Keller Enhanced delivery of antifungal agents
US20090291132A1 (en) * 2008-01-04 2009-11-26 Brian Charles Keller Enhanced delivery of antifungal agents
JP2011508780A (en) * 2008-01-04 2011-03-17 ケラー，ブライアン，チャールズ Enhanced delivery of antifungal drugs
WO2009105294A2 (en) * 2008-02-20 2009-08-27 Elc Management Llc Topical compositions and methods for whitening skin
CN102159216A (en) * 2008-07-17 2011-08-17 G·莱维斯 Methods and materials for acne treatment
EP2343980A4 (en) * 2008-09-08 2012-06-06 Nian Wu Triazole antifungal agents
US8524258B2 (en) * 2008-12-22 2013-09-03 Johnson & Johnson Consumer Companies, Inc. Structured lotions
JP2012515774A (en) * 2009-01-23 2012-07-12 ケラー，ブライアン，チャールズ PEG-lipid conjugates that increase the solubility of drug compounds
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
WO2010141068A1 (en) * 2009-06-02 2010-12-09 Wu Nian Opthalmic compositions of cyclosporin
WO2011006100A1 (en) * 2009-07-09 2011-01-13 Crescendo Therapeutics, Llc Method of wound healing and scar modulation
US20110105387A1 (en) * 2009-09-19 2011-05-05 Nian Wu Method of treatment with rapamycin
CO6280050A1 (en) * 2010-06-08 2011-05-20 Sante S A Lab PHARMACEUTICAL FORM OF PHOSPHODESTERASE INHIBITORS FOR TRANSMUCOUS ADMINISTRATION
US9352291B2 (en) 2011-09-23 2016-05-31 The University Of Southern Mississippi Dispersant for spilled oil
US9775803B2 (en) 2011-10-19 2017-10-03 Samsung Electronics Co., Ltd. Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof
WO2013109421A1 (en) 2012-01-05 2013-07-25 Guilford Frederick Timothy Liposomally encapsulated reduced glutathione for management of cancer and disruption of cancer energy cycles
WO2013103840A1 (en) 2012-01-05 2013-07-11 Guilford Frederick Timothy Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione
US10548841B2 (en) * 2012-08-21 2020-02-04 Opko Pharmaceuticals, Llc Liposome formulations
US11458199B2 (en) 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
US9616132B2 (en) 2013-03-15 2017-04-11 Dow Pharmaceutical Sciences, Inc. Kinetin/zeatin topical formulation
US20140328898A1 (en) * 2013-03-15 2014-11-06 Children's National Medical Center Nano-Liposomal Formulations and Methods of Use
PL3081207T3 (en) 2015-04-16 2023-03-20 Symrise Ag Use of a liposome composition
EP3324993B1 (en) 2015-07-21 2024-09-04 Emory University Liposomal reduced glutathione for treatment of rsv
JP6924431B2 (en) * 2015-10-13 2021-08-25 株式会社ケーナインラボ How to administer the drug to mammals other than humans
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US10702475B2 (en) 2017-09-05 2020-07-07 Richard Rigg Liposome containing compositions and their use in personal care and food products
JP6297737B1 (en) * 2017-09-25 2018-03-20 ジェイ−ネットワーク，インコーポレイテッド Method for preparing positively charged charged niosomes and charged niosomes
CN108392637B (en) * 2018-03-30 2021-05-18 浙江海昶生物医药技术有限公司 Posaconazole liposome and preparation method thereof
JP6860739B1 (en) 2020-11-20 2021-04-21 ジェイ−ネットワーク，インコーポレイテッド Antioxidant expression enhancer in the epidermis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79114A (en) 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US5358714A (en) * 1988-03-23 1994-10-25 Unilever Patent Holdings B.V. Cosmetic composition
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5720973A (en) * 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4410238A1 (en) * 1994-03-25 1995-09-28 Beiersdorf Ag Skin care products
JPH07316040A (en) * 1994-03-29 1995-12-05 Res Dev Corp Of Japan Reconstituted liposome and method for introducing substance
SE518578C2 (en) * 1994-06-15 2002-10-29 Gs Dev Ab Lipid-based composition
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
IT1270678B (en) 1994-10-20 1997-05-07 Bayer Ag KETOPROFEN LIPOSOMES
US5859228A (en) * 1995-05-04 1999-01-12 Nexstar Pharmaceuticals, Inc. Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US6284267B1 (en) * 1996-08-14 2001-09-04 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
AU8053898A (en) * 1997-05-28 1998-12-30 Jenner Biotherapies, Inc. Immunogenic compositions
DK1017365T3 (en) * 1997-06-23 2004-03-29 Alza Corp Liposome enclosed polynucleotide composition and method
US6734171B1 (en) * 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers
JP2000229815A (en) * 1999-02-05 2000-08-22 Toshimitsu Hattori Liposomes and their use
JP4444385B2 (en) * 1999-02-25 2010-03-31 帝人株式会社 Liposome preparation kit
CA2370690A1 (en) * 1999-04-20 2000-10-26 The University Of British Columbia Cationic peg-lipids and methods of use
CO5170451A1 (en) * 1999-04-23 2002-06-27 Kimberly Clark Co WET CLEANING PANOS THAT HAVE HEALTH BENEFITS FOR THE SKIN
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US7785623B2 (en) * 2002-10-01 2010-08-31 Keller Brian C Compositions and methods useful for the reduction of fine lines and wrinkles

Also Published As

Publication number Publication date
US7718190B2 (en) 2010-05-18
JP4497765B2 (en) 2010-07-07
US20110064791A1 (en) 2011-03-17
US20050249797A1 (en) 2005-11-10
US7150883B2 (en) 2006-12-19
JP2002212106A (en) 2002-07-31
US20070042032A1 (en) 2007-02-22
ATE429901T1 (en) 2009-05-15
EP1343475B1 (en) 2009-04-29
WO2002049617A2 (en) 2002-06-27
JP2010001318A (en) 2010-01-07
US6958160B1 (en) 2005-10-25
EP1343475A2 (en) 2003-09-17
WO2002049617A3 (en) 2003-01-23
DE60138566D1 (en) 2009-06-10
US6610322B1 (en) 2003-08-26

Similar Documents

Publication Publication Date Title
AU2002232788A1 (en) Self forming, thermodynamically stable liposomes and their applications
MXPA02012068A (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations.
DK0703786T3 (en) Use of nona- and decapeptides for the manufacture of a medicament for the treatment of AIDS
AU2001234567A1 (en) Guaranteed exactly once delivery of messages
AU8178601A (en) Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds
AU2001278124A1 (en) Novel microemulsion and micelle systems for solubilizing drugs
MY118151A (en) Pharmaceutical formulations containing voriconazole.
AU2845599A (en) Pharmaceutical compositions and their use
WO2003096973A3 (en) A direct cellular energy delivery system
HUP0300882A3 (en) New self emulsifying drug delivery system
AU2001234114A1 (en) Drugs containing combined active ingredients
AU7056001A (en) Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
AU6887401A (en) Delivery of remotely-ordered products
IL150528A0 (en) Ibuprofen containing active agent preparation
IL151380A0 (en) New self emulsifying drug delivery system
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
AU2002224439A1 (en) Personal gas supply delivery system
CA2436572A1 (en) Perylenequinones for use as photosensitizers and sonosensitizers
WO2003035032A3 (en) New non-phospholipid lipid vesicles (nplv) and their use in cosmetic, therapeutic and prophylactic applications
CA2402708A1 (en) Torasemide-containing pharmaceutical preparations
DE50208813D1 (en) (ester)-lysolecithine in liposomen
WO2004037223A3 (en) Liposome-forming compositions
CY1108791T1 (en) PLANT CONDITIONER
AUPQ866500A0 (en) Therapeutic compounds and methods
MY136370A (en) Oxazolidinone tablet formulation